Skip to main content
Offering could pull in $41M for Senseonics

An underwritten offering of common stock involving a group of institutional investors, including Roche Finance, has been priced by Senseonics in hopes of raising $41 million. Net proceeds from the offering of 29 million shares will be used as working capital, as well as to support US commercialization of the Eversense continuous glucose monitor and research and development efforts for the device's next-generation versions.

Full Story: